𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma

✍ Scribed by Mark P. Macfarlane; James C. Yang; Anshu S. Guleria; Richard L White Jr.; Claudia A. Seipp; Jan H. Einhorn; Donald E. White; Steven A. Rosenberg

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
744 KB
Volume
75
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Surgical resection of metastatic renal c
Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy
✍ Dr. Richard M. Shery; Harvey I. Pass; Steven A. Rosenberg; James C. Yang πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 473 KB πŸ‘ 2 views

Thirty-one patients with disseminated melanoma or renal cell cancer (RCC) who had a limited relapse or persistent disease after a partial or complete response to interleukin-2 (IL-z)-based immunotherapy underwent resection of progressing tumors or residual sites of disease. There were no surgery-rel

Phase 2 trial of talactoferrin in previo
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma
✍ Eric Jonasch; Walter M. Stadler; Ronald M. Bukowski; Teresa G. Hayes; Atul Varad πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Talactoferrin (TLF), a recombinant form of human lactoferrin (hLF), is an immunomodulatory iron‐binding glycoprotein first identified in breast milk. Its immunomodulatory functions include activation of natural killer (NK) and lymphokine‐activated killer cells and enhanc